Researchers at the University of Texas Medical Branch, Galveston, have provided substantial evidence supporting the potential role of statins in mitigating venous thromboembolism (VTE) risk associated with hormone therapy ...
The Ultrasound and Elasticity Imaging Laboratory, led by Elisa Konofagou, Robert and Margaret Hariri Professor of Biomedical Engineering, develops novel, ultrasound-based techniques for both imaging and therapeutic applications.
Sep 13, 2023
0
46
Researchers at Duke University have adapted CRISPR technologies for high-throughput screening of gene function in human immune cells and discovered that a single master regulator of the genome can be used to reprogram a network ...
Nov 9, 2023
0
60
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, ...
Aug 28, 2023
0
46
A study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids, which can have significant side effects.
Dec 8, 2023
0
46
People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several ...
Sep 29, 2023
0
8
Research led by the Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, has found a potentially better alternative to standard antiretroviral treatment for controlling HIV-1 ...
A type of gene therapy that precisely "edits" a key bit of DNA might offer a new way to treat sickle cell disease—a painful inherited condition that largely strikes Black children and adults.
Sep 3, 2023
0
10
A ZIP code in Miami Beach, known for its vibrant nightlife, is a hot spot for new HIV infections.
Dec 5, 2023
0
0
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
